blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0868434

EP0868434 - ANTI-IDIOTYPIC ANTIBODIES OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND USE THEREOF AS DRUGS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.08.2003
Database last updated on 05.10.2024
Most recent event   Tooltip12.06.2009Change - representativepublished on 15.07.2009  [2009/29]
Applicant(s)For all designated states
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS-
3, rue Michel-Ange
75016 Paris / FR
[N/P]
Former [2002/41]For all designated states
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
3, rue Michel Ange
75016 Paris / FR
Former [1998/41]For all designated states
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
3, rue Michel Ange
75016 Paris / FR
Inventor(s)01 / PLOUET, Jean
29, rue Noulet
F-31400 Toulouse / FR
02 / JONCA, Frédéric
12, place Marnac
F-31520 Ramonville-Saint-Agne / FR
03 / ORTEGA, Nathalie
Appartement 3, 10, rue Elvire
F-31400 Toulouse / FR
04 / RUCHOUX, Marie-Magdeleine
50, rue Croix-Pasquier
F-37100 Tours / FR
[1998/41]
Representative(s)Grosset-Fournier, Chantal Catherine
Grosset-Fournier & Demachy
54, rue Saint-Lazare
75009 Paris / FR
[N/P]
Former [2009/29]Grosset-Fournier, Chantal Catherine
Grosset-Fournier & Demachy 54 Rue Saint-Lazare
75009 Paris / FR
Former [1998/41]Grosset-Fournier, Chantal Catherine
Grosset-Fournier & Demachy s.a.r.l., 103 rue La Fayette
75481 Paris Cédex 10 / FR
Application number, filing date96943157.620.12.1996
[1998/41]
WO1996FR02041
Priority number, dateFR1995001524321.12.1995         Original published format: FR 9515243
[1998/41]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9723510
Date:03.07.1997
Language:FR
[1997/29]
Type: A1 Application with search report 
No.:EP0868434
Date:07.10.1998
Language:FR
The application published by WIPO in one of the EPO official languages on 03.07.1997 takes the place of the publication of the European patent application.
[1998/41]
Type: B1 Patent specification 
No.:EP0868434
Date:09.10.2002
Language:FR
[2002/41]
Search report(s)International search report - published on:EP03.07.1997
ClassificationIPC:C07K16/42, A61K39/395, A61K47/48, A61K51/10, G01N33/53
[1998/41]
CPC:
C07K16/4241 (EP,US); A61P27/00 (EP); A61P27/02 (EP);
A61P35/00 (EP); A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IT,   LI,   NL,   SE [1998/41]
TitleGerman:VASKULARE ENDOTHELZELLE-WACHSTUMSFAKTOR ANTIIDOTYPISCHE ANTIKÖRPER UND IHRE VERWENDUNG ALS ARZNEIMITTEL[1998/41]
English:ANTI-IDIOTYPIC ANTIBODIES OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND USE THEREOF AS DRUGS[1998/41]
French:ANTICORPS ANTI-IDIOTYPIQUES DU FACTEUR DE CROISSANCE ENDOTHELIALE VASCULAIRE ET LEUR UTILISATION COMME MEDICAMENTS[1998/41]
Entry into regional phase10.07.1998National basic fee paid 
10.07.1998Designation fee(s) paid 
10.07.1998Examination fee paid 
Examination procedure25.06.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.07.1998Examination requested  [1998/41]
24.10.2001Despatch of communication of intention to grant (Approval: No)
22.04.2002Despatch of communication of intention to grant (Approval: later approval)
30.04.2002Communication of intention to grant the patent
02.07.2002Fee for grant paid
02.07.2002Fee for publishing/printing paid
Opposition(s)10.07.2003No opposition filed within time limit [2003/40]
Fees paidRenewal fee
18.12.1998Renewal fee patent year 03
27.12.1999Renewal fee patent year 04
28.12.2000Renewal fee patent year 05
27.12.2001Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipDK09.01.2003
SE09.01.2003
[2007/17]
Former [2003/27]SE09.01.2003
Cited inInternational search[A]EP0502416  (AMERICAN CYANAMID CO [US]) [A] * page 3, line 36 - line 53 *;
 [A]WO9411499  (MAX PLANCK GESELLSCHAFT [DE]) [A] * page 3, line 2 - line 26 * * page 23, line 3 - page 24, line 12 * * page 26, line 28 - page 28, line 33 * * page 34, line 11 - page 35, line 7 *;
 [X]  - PLOUET ET AL, "VEGF DEPENDENT TUMORAL PROGRESSION: STIMULATION BY ANTI VEGF IDIOTYPIC ANTIBODIES", JOURNAL OF CELLULAR BIOCHEMISTRY.SUPPLEMENT 18A, (1994), page 328, XP000602723 [X] 1-15 * abrégé EZ311 *
 [DA]  - TERMAN ET AL, "IDENTIFICATION OF THE KDR TYROSINE KINASE AS A RECEPTOR FOR VASCULAR ENDOTHELIAL CELL GROWTH FACTOR", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (1992), vol. 187, pages 1579 - 1586, XP002013861

DOI:   http://dx.doi.org/10.1016/0006-291X(92)90483-2
 [DA]  - MILLAUER ET AL, "HIGH AFFINITY VEGF BINDING AND DEVELOPMENTAL EXRPESSSION SUGGEST FLK-1 AS A MAJOR REGULATOR OF VASCULOGENESIS AND ANGIOGENESIS", CELL, (1993), vol. 72, pages 835 - 846, XP002013862

DOI:   http://dx.doi.org/10.1016/0092-8674(93)90573-9
 [DA]  - MILLAUER ET AL, "GLIOBLASTOMA GROWTH INHIBITED IN VIVO BY A DOMINANT-NEGATIVE FLK-1 MUTANT", NATURE, (1994), vol. 367, pages 576 - 579, XP002013863

DOI:   http://dx.doi.org/10.1038/367576a0
 [DA]  - JIN KIM ET AL, "INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED ANGIOGENESIS SUPPRESSES TUMOUR GROWTH IN VIVO", NATURE, (1993), vol. 362, pages 841 - 844, XP002013864

DOI:   http://dx.doi.org/10.1038/362841a0
 [A]  - CHAGNAUD ET AL, "CURATIVE EFFECTS ON RAT SARCOMAS OBTAINED AFTER A TREATMENT COMBINING TWO MONOCLONAL ANTIBODIES", ANTI-CANCER DRUGS, (1994), vol. 5, pages 361 - 366, XP000601953 [A] * page 361,abrégé,page 365,'conclusion' *

DOI:   http://dx.doi.org/10.1097/00001813-199406000-00015
 [PX]  - ORT GA ET AL, "MODULATION DE LA PROGRESSION TUMORALE PAR DES ANTICORPS ANTI-IDIOTYPIQUES DE FACTEURS ANGIOG NIQUES", C.R.ACAD.SCI.PARIS,SCIENCE DE LA VIE, (199605), vol. 319, pages 411 - 415, XP000601935 [PX] 1-15 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.